secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001628280-24-030244
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio prices $4.0M public offering of shares and warrants at $1.83/unit
-------------------------------------------------------------------------

- Offering of 2,185,793 shares (or equivalents) plus Series C-1 and C-2 warrants at $1.83 per unit.
- Gross proceeds ~$4.0M, net proceeds ~$3.2M after 7% placement agent fee and expenses.
- Warrants exercisable at $1.83/share upon stockholder approval; C-1 expires 5 yrs, C-2 expires 18 months.
- Proceeds allocated to product candidate development, working capital, and general corporate purposes.
- H.C. Wainwright is exclusive placement agent; closing expected on or about June 28, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000162828024030244/0001628280-24-030244-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000162828024030244/val-20240626.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-030244

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer